Eva Ciruelos
Research Institute Hospital 12 de Octubre(ES)Hospital Universitario 12 De Octubre(ES)HM Hospitales(ES)Solti(ES)Hospital Universitari Sant Joan de Reus(ES)Spanish Ovarian Cancer Research Group(ES)GEICAM – Spanish Breast Cancer Group(ES)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer(2015)2,084 cited
- → Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort(2010)1,254 cited
- → De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017(2017)1,245 cited
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study(2013)992 cited
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study(2020)865 cited